|
STARD3NL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63113966777928E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.04440001091888E-09 |
| Normal-vs-Stage2 |
8.167100E-04 |
| Normal-vs-Stage3 |
5.90040000000291E-05 |
| Normal-vs-Stage4 |
8.99050000002788E-08 |
| Stage1-vs-Stage2 |
8.358800E-01 |
| Stage1-vs-Stage3 |
5.510600E-01 |
| Stage1-vs-Stage4 |
3.380800E-01 |
| Stage2-vs-Stage3 |
7.641000E-01 |
| Stage2-vs-Stage4 |
6.454800E-01 |
| Stage3-vs-Stage4 |
8.536800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64679381242649E-12 |
| Normal-vs-AfricanAmerican |
9.83650000008218E-07 |
| Normal-vs-Asian |
1.015820E-01 |
| Caucasian-vs-AfricanAmerican |
4.403400E-01 |
| Caucasian-vs-Asian |
6.301600E-01 |
| AfricanAmerican-vs-Asian |
4.451600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29862787190405E-12 |
| Normal-vs-Female |
4.36179981022633E-10 |
| Male-vs-Female |
6.080000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.757600E-04 |
| Normal-vs-Extreme_Weight |
1.12990000022961E-07 |
| Normal-vs-Obese |
1.45140000018529E-09 |
| Normal-vs-Extreme_Obese |
1.343970E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.417600E-01 |
| Normal_Weight-vs-Obese |
3.714800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.937000E-01 |
| Extreme_Weight-vs-Obese |
8.228200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.455600E-01 |
| Obese-vs-Extreme_Obese |
7.067600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.789410E-04 |
| Normal-vs-Age(41-60Yrs) |
3.88578058618805E-13 |
| Normal-vs-Age(61-80Yrs) |
1.11139997205356E-09 |
| Normal-vs-Age(81-100Yrs) |
2.803900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.368000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.753400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.564400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.718400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.658000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.952400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62481139653892E-12 |
| Normal-VS-Type2 PRCC |
3.74800000000342E-05 |
| Normal-VS-KIRP CIMP |
3.025800E-02 |
| Normal-VS-Unclassified PRCC |
5.9257999999951E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.624000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.203200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.688200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.867000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.809430E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.120400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.67160000000122E-05 |
| Normal-vs-N1 |
2.46219999999742E-05 |
| Normal-vs-N2 |
9.9124000000006E-05 |
| N0-vs-N1 |
7.466100E-02 |
| N0-vs-N2 |
6.070200E-01 |
| N1-vs-N2 |
7.207400E-01 |
|
|
